These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 5769363)

  • 1. Cytology screening--a program that works.
    MacLean MA
    Can Nurse; 1969 May; 65(5):40-3. PubMed ID: 5769363
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass cervical cancer screening program by irrigation smear in Japan.
    Kawashima Y; Ino S; Tashiro K; Tachibana M; Masukawa T
    Obstet Gynecol; 1968 Jul; 32(1):17-23. PubMed ID: 5742086
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaginal-cytological examination. Routine examination of a symptom-free young clientele].
    Hastrup J; Rojel K
    Ugeskr Laeger; 1968 Feb; 130(6):243-5. PubMed ID: 5676294
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of pipette and smear methods in population screenings for carcinoma of the uterine cervix.
    Klinken L; Koch F; Albrechtsen R
    Dan Med Bull; 1972 Jun; 19(4):138-40. PubMed ID: 5041571
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynaecological mass screening in Finland.
    Timonen S
    Minerva Ginecol; 1971 Jan; 23(1):7-11. PubMed ID: 5553187
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytologic screening--an effective method].
    MacLean MA
    Infirm Can; 1970 Feb; 12(2):23-7. PubMed ID: 5197343
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of physical findings in diagnosis of cervical carcinoma.
    Moller KA; Fogh H; Moller PE; Strandbygard K
    Dan Med Bull; 1972 Jun; 19(4):122-7. PubMed ID: 5041568
    [No Abstract]   [Full Text] [Related]  

  • 9. Mass screening for cancer and precancerous conditions of cervix uteri. A preliminary report.
    Messelt OT; Höeg K
    Acta Cytol; 1967; 11(1):39-40. PubMed ID: 5230439
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current aspects of diagnostic cytology in invasive cervical carcinoma (author's transl)].
    Bajardi F; Holzer E
    Wien Klin Wochenschr; 1973 Oct; 85(42):714-8. PubMed ID: 4766058
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for cancer of the female genital tract in general medical and surgical wards.
    Wachtel E; Wycherley J; Lee CN
    Practitioner; 1972 Apr; 208(246):505-8. PubMed ID: 5031038
    [No Abstract]   [Full Text] [Related]  

  • 12. Barriers to cervical cytology screening in native women in British Columbia.
    Deschamps M; Band PR; Hislop TG; Clarke HF; Smith JM; To Yee Ng V
    Cancer Detect Prev; 1992; 16(5-6):337-9. PubMed ID: 1473122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine cervical screening of in-patients in a voluntary hospital.
    McDonald JR
    Acta Cytol; 1969 Aug; 13(8):455-8. PubMed ID: 5259258
    [No Abstract]   [Full Text] [Related]  

  • 14. Is cervical carcinoma in situ a significant lesion?
    Green GH
    Int Surg; 1967 Jun; 47(6):511-7. PubMed ID: 6033236
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges in screening for cancer of the cervix: delivery, technology and evaluation of programs.
    Morgan PP
    Can Med Assoc J; 1982 Oct; 127(7):571-2. PubMed ID: 7127224
    [No Abstract]   [Full Text] [Related]  

  • 16. Positive smears in previously screened patients (certain cytologic findings of public health importance).
    Liu W
    Acta Cytol; 1967; 11(3):193-8. PubMed ID: 5232017
    [No Abstract]   [Full Text] [Related]  

  • 17. Statistical methods in a screening program for cancer.
    Renwick DH
    Can J Public Health; 1969 Jul; 60(7):267-78. PubMed ID: 5804452
    [No Abstract]   [Full Text] [Related]  

  • 18. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reply to comment on Pathologica 1998; 90:357-363].
    Bondi A
    Pathologica; 1999 Feb; 91(1):63. PubMed ID: 10438283
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for cervical cancer. Canadian programmatic guidelines.
    Parboosingh J
    Can Fam Physician; 1999 Feb; 45():383-93. PubMed ID: 10065312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.